Prevention of recurrences of life-threatening ventricular tachycardia or ventricular fibrillation, symptomatic ventricular tachycardia; supraventricular tachycardia; heat rhythm disorders in case of resistance to or contraindication of other treatments; heart rhythm disorders attributable to WPW syndrome.Treatment of supraventricular tachycardia to slow down the heart rate or to restore the sinus rhythm in cases of atrial fibrillation and atrial flutter. 
The medication is recommended for patients with ischemic heart disease and/or impaired left ventricular function for managing documented supraventricular tachycardia to control the heart rate in case of atrial fibrillation and atrial flutter.

Induction in anesthesia. As a further means for the base anesthesia (with the subsequent use of analgesics and muscle relaxants). As an additional means for the relief of convulsive states of various etiologies, including causes by the use of a local anesthetic. To reduce intracranial pressure in patients with increased intracranial pressure during mechanical ventilation.

Hepatitis of various origin, cholecystitis, myocarditis, cardiomyopathy associated with metabolic disorders, ischemic heart disease (as an adjunctive treatment) and postoperative complications.

Hepatitis of various origin, cholecystitis, myocarditis, cardiomyopathy associated with metabolic disorders, ischemic heart disease (as an adjunctive treatment) and postoperative complications.

In the complex treatment of ischemic heart disease: angina, myocardial infarction, postinfarction cardiosclerosis; as additional treatment in the treatment of cardiac arrhythmias. In the complex treatment of chronic hepatitis, alcoholic hepatitis, liver fibrosis and cirrhosis.

In the complex treatment of ischemic heart disease: angina, myocardial infarction, postinfarction cardiosclerosis; as additional treatment in the treatment of cardiac arrhythmias. In the complex treatment of chronic hepatitis, alcoholic hepatitis, liver fibrosis and cirrhosis.

Treatment of ischemic stroke and its consequences, such as speech disorders, mental and somatic illnesses, decreased activity, emotional disorders; treatment (in the rehabilitation period) of the vascular, toxic and traumatic encephalopathy; treatment of alcohol withdrawal syndrome, diabetic encephalopathy; hypersensitivity to tiazotic acid and/or piracetam; end-stage of renal disease; Huntington's disease; hemorrhagic stroke.

Thiocetam forte is used in neurological practice for transient and chronic cerebrovascular disorders associated with cerebral atherosclerosis and transient disturbances of brain circulation.The drug is also indicated for cerebrovascular disorders, disturbances of brain metabolism attributable to head injury, intoxication, diabetic encephalopathy, as well as during subacute and the rehabilitation period after ischemic and hemorrhagic strokes.